potassium phosphates
Generic: potassium phosphates
Labeler: hospira, inc.Drug Facts
Product Profile
Brand Name
potassium phosphates
Generic Name
potassium phosphates
Labeler
hospira, inc.
Dosage Form
INJECTION, SOLUTION, CONCENTRATE
Routes
Active Ingredients
dibasic potassium phosphate 236 mg/mL, monobasic potassium phosphate 224 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
0409-0032
Product ID
0409-0032_bc88fab4-5971-468e-b2e0-907a4d91899d
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA217459
Listing Expiration
2026-12-31
Marketing Start
2025-09-29
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
04090032
Hyphenated Format
0409-0032
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
potassium phosphates (source: ndc)
Generic Name
potassium phosphates (source: ndc)
Application Number
ANDA217459 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 236 mg/mL
- 224 mg/mL
Packaging
- 25 VIAL, SINGLE-DOSE in 1 TRAY (0409-0032-01) / 15 mL in 1 VIAL, SINGLE-DOSE (0409-0032-10)
Packages (1)
Ingredients (2)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "bc88fab4-5971-468e-b2e0-907a4d91899d", "openfda": {"unii": ["CI71S98N1Z", "4J9FJ0HL51"], "rxcui": ["1928569"], "spl_set_id": ["2fcbc814-c7a4-469a-8b1d-6819b961bfb9"], "manufacturer_name": ["Hospira, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "25 VIAL, SINGLE-DOSE in 1 TRAY (0409-0032-01) / 15 mL in 1 VIAL, SINGLE-DOSE (0409-0032-10)", "package_ndc": "0409-0032-01", "marketing_start_date": "20250929"}], "brand_name": "Potassium Phosphates", "product_id": "0409-0032_bc88fab4-5971-468e-b2e0-907a4d91899d", "dosage_form": "INJECTION, SOLUTION, CONCENTRATE", "pharm_class": ["Increased Large Intestinal Motility [PE]", "Increased Large Intestinal Motility [PE]", "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]", "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]", "Osmotic Activity [MoA]", "Osmotic Activity [MoA]", "Osmotic Laxative [EPC]", "Osmotic Laxative [EPC]", "Potassium Compounds [CS]", "Potassium Compounds [CS]", "Potassium Salt [EPC]", "Potassium Salt [EPC]"], "product_ndc": "0409-0032", "generic_name": "potassium phosphates", "labeler_name": "Hospira, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Potassium Phosphates", "active_ingredients": [{"name": "DIBASIC POTASSIUM PHOSPHATE", "strength": "236 mg/mL"}, {"name": "MONOBASIC POTASSIUM PHOSPHATE", "strength": "224 mg/mL"}], "application_number": "ANDA217459", "marketing_category": "ANDA", "marketing_start_date": "20250929", "listing_expiration_date": "20261231"}